First cases of BSE in USA and Canada: risk assessment of ruminant materials originating from USA and Canada - Scientific guideline
HumanScientific guidelines
This document considers the implications of the first Canadian and US BSE case on medicinal products that contain, or use during their manufacture, ruminant materials of Canadian or US origin.
Keywords: Bovine spongiform encelophathy (BSE), transmissible spongiform encephalopathy (TSE), USA, Canada, blood, serum, gelatine, calf, risk
Current effective version
Related content
- Biologicals: finished product
Gelatin for use in pharmaceuticals: explanatory note (13 december 2000) on the manufacture of gelatin in relationship to the CPMP note For guidance on minimising the risk of transmitting Animal Spongiform Encephalopathy ...- Minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products - Scientific guideline
- Production of tallow derivatives for use in pharmaceuticals
- Risk and regulatory assessment of lactose and other products prepared using calf rennet